文献速递瓣膜外科

妊娠期瓣膜置换:ROPAC III 新数据与文献综述

Valve replacement during pregnancy: literature review including new data from the Registry Of Pregnancy And Cardiac disease III.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本研究结合 ROPAC III 注册研究新数据与系统文献综述,描述妊娠期瓣膜置换的母婴结局。ROPAC III 纳入 2018 年 1 月至 2023 年 4 月全球妊娠合并人工瓣膜女性,其中 11 例妊娠期行瓣膜置换。文献汇总 74 例,总体母体死亡率 9%、胎儿死亡率 34%;置换现有人工瓣膜是胎儿死亡预测因素。

要点

  • 妊娠期瓣膜置换母婴死亡风险高,胎儿死亡率达 34%。
  • 置换现有人工瓣膜与胎儿死亡率升高相关(OR 4.8)。
  • 孕早期置换和现有瓣膜急性功能障碍预测母体死亡。

核心结论

  • 妊娠期瓣膜置换伴随高母体和胎儿死亡率,尤其在需要置换现有人工瓣膜的女性中。

研究设计与样本

  • 系统综述,结合 ROPAC III 全球前瞻性观察注册研究(2018 年 1 月至 2023 年 4 月纳入妊娠合并至少 1 个人工瓣膜女性)与文献数据。
  • ROPAC III 中 11 例妊娠期行瓣膜置换;文献检索纳入妊娠期行瓣膜置换且胎儿在宫内的研究,共 74 例。
  • 主要结局为母体和胎儿死亡;采用混合效应逻辑回归识别预测因素。

主要发现

  • ROPAC III 中 11 例妊娠期瓣膜置换,1 例母体和胎儿死亡,2 例发生可逆性术后并发症。
  • 文献 74 例汇总分析显示总体母体死亡率为 9%,胎儿死亡率为 34%。
  • 所有母体死亡均发生于置换二尖瓣位置人工瓣膜的女性。
  • 孕早期瓣膜置换(OR 10.0)和现有人工瓣膜急性功能障碍(OR 19.7)为母体死亡预测因素。
  • 置换现有人工瓣膜(OR 4.8)为胎儿死亡预测因素。

临床怎么用

  • 妊娠期瓣膜置换决策需充分权衡高母胎死亡风险,尤其需置换现有人工瓣膜时。
  • 对现有人工瓣膜急性功能障碍和孕早期需置换者应加强预警与多学科管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Heart valve replacement during pregnancy is sometimes unavoidable, and the need for anticoagulation further complicates these procedures. Our study describes cases of valve replacement in pregnancy enrolled in the Registry Of Pregnancy And Cardiac disease (ROPAC) III and gives an overview of the published literature. METHODS: We performed a systematic review with new data from the ROPAC III and data available in the literature. ROPAC III is a global, prospective, observational registry that included pregnant women with 1 or more prosthetic valves between January 2018 and April 2023. Electronic databases were searched for studies enrolling pregnant women who underwent valve replacement during pregnancy with a fetus in utero. The primary outcomes were maternal and fetal death. Mixed-effect logistic regression models were used to identify predictors for maternal and fetal mortality. RESULTS: A valve replacement was performed in 11 pregnancies. The mother and fetus died in 1 case, and in 2 cases, reversible postoperative complications occurred. We found 74 cases in the literature and calculated an overall maternal and fetal death rate of 9% and 34%, respectively. All maternal deaths occurred in women with a replacement of a prosthetic valve in mitral position. We found valve replacement in the 1st trimester (OR 10.0) and acute malfunctioning of an existing prosthetic valve (OR 19.7) as predictors for maternal mortality, and replacement of an existing prosthetic valve (OR 4.8) as predictor for fetal mortality. CONCLUSIONS: Valve replacement during pregnancy carries a high maternal and fetal death, especially in women who need a replacement of an existing prosthetic valve.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. van der Zande JA, Siromakha S, Peters PNJ, et al. Valve replacement during pregnancy: literature review including new data from the Registry Of Pregnancy And Cardiac disease III. Eur J Cardiothorac Surg. 2025. PMID: 40578618. doi:10.1093/ejcts/ezaf180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。